Rapidly Controls Bleeding After Radial Catheterization Procedures. Effective Hemostasis for Anticoagulated Patients

SyvekRadial® Patch promotes control of bleeding from radial access sites through the use of poly-N-acetyl glucosamine (pGlcNAc) fibers derived from microalgae. These fibers effectively control bleeding for patients on anticoagulation therapies.3

  • Proven results in anticoagulated patients3
  • Allows for very short compression times1
  • Preserves radial artery patency1

Distinct Advantages for Transradial Catheterization

The SyvekRadial® system consists of three components:

  • SyvekRadial® Patch accelerates hemostasis
  • Syvek® Brace supports and immobilizes either wrist
  • SyvekRadial® Band allows for easy, self-contained bladder inflation and deflation

The SyvekRadial® Band bladder is designed to target the radial artery only, preserving ulnar artery patency.

Helps to Achieve Fast Hemostasis and Preserve Radial Artery Patency

The standard of care post-procedure for transradial access has been prolonged manual compression (2-6 hours). A U.S. trial studied the effects of using the pGlcNAc fibers found in the SyvekRadial® Patch to facilitate shorter compression times in 50 patients. The first 15 patients acted as a roll-in group for device and procedure standardization. The remaining 35 were assigned to the compression group for diagnostic (n=26) and interventional procedures (n=9). Patients were randomized to 10, 30, or 60 minute compression times.1

  • Hemostasis was successful in 97% of the compression patients (n=50).
  • 31 of the compression patients had Barbeau Class A plethysmography, 3 had Class B, and only 1 radial artery was occluded (radial patency resolved in 1 hour).
  • No complications were reported in any of the 50 patients.


Download Product Sell Sheet



Indications for Use:
Syvek® Patch promotes the rapid control of bleeding in patients following hemodialysis and in patients on anticoagulation therapy. Syvek® Patch is indicated for use in the local management of bleeding wounds such as vascular access site, percutaneous catheters or tubes and surgical debridement. Syvek® Patch is intended for use under the direction of a healthcare professional.

Safety Information:
PRECAUTIONS: There are no known contraindications to the use of Syvek® Patch. Longer compression may be necessary for patients who are hypertensive or who are obese. For external use only.
Not made with Natural Rubber Latex
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner. For external use only.

Manufactured by Marine Polymer Technologies, Inc. For instructions for use or additional product information, please contact us.

  • 9,867,625, 8,992,453
  • 8,859,528
  • 8,835,408
  • 8,481,512
  • 8,152,750
  • 7,931,637
  • 7,115,588
  • 7,041,657
  1. Turi Z, McEniry B, Aji J, et al. Cathet Cardiovasc Intervent. 2012; 79:S1–S110.
  2. Valeri C, Vournakis J. J Trauma. 2011; 71:S162–S166.
  3. Nader R, Garcia J, Drushal K, et al. J Invas Cardiol. 2002; 14:305-307.

*Please see the “Instructions for Use” supplied in each package, for detailed product instructions.